Efficacy and safety of Lignosus rhinocerus (Cooke) Ryvarden TM02® supplementation for immune-challenged patients with localised breast cancer in remission: a randomised controlled trial

Efficacy and safety of Lignosus rhinocerus (Cooke) Ryvarden TM02® supplementation for immune-challenged patients with localised breast cancer in remission: a randomised controlled trial

Abstract Purpose of study This study aimed to evaluate the safety and effectiveness of TM02® in improving health-related quality of life (HRQoL) and fatigue in patients with localized breast cancer who had completed surgery and chemotherapy, addressing both acute and long-term side effects. Methods...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Yi Eng, Po Lin Ooi, Mariam Zafirah, Mahmoud Danaee, Marniza Saad, Muhammad Fazril Mohamad Razif, Nor Aishah Taib, Chee Loong Lam, Zamri Chik, Shin-Yee Fung
Format: Article
Language:English
Published: BMC 2025-05-01
Series:BMC Complementary Medicine and Therapies
Subjects:
Breast cancer
Chemotherapy
TM02®
Quality of life
Chemotherapy-induced fatigue
Chemotherapy-induced cognitive impairment
Online Access:https://doi.org/10.1186/s12906-025-04919-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12906-025-04919-6

Similar Items